Your browser doesn't support javascript.
loading
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
Sulkowski, M S; Feld, J J; Lawitz, E; Felizarta, F; Corregidor, A M; Khalid, O; Ghalib, R; Smith, W B; Van Eygen, V; Luo, D; Vijgen, L; Gamil, M; Kakuda, T N; Ouwerkerk-Mahadevan, S; Van Remoortere, P; Beumont, M.
Afiliação
  • Sulkowski MS; Divisions of Infectious Diseases and Hepatology/Gastroenterology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Feld JJ; Toronto Center for Liver Disease, Toronto General Hospital, Toronto, ON, Canada.
  • Lawitz E; Texas Liver Institute, University of Texas Health, San Antonio, TX, USA.
  • Felizarta F; Private Practice, Bakersfield, CA, USA.
  • Corregidor AM; Borland-Groover Clinic PA, Jacksonville, FL, USA.
  • Khalid O; Digestive Health Specialists, Winston-Salem, NC, USA.
  • Ghalib R; North Texas GI Surgery Center, Arlington, TX, USA.
  • Smith WB; NOCCR/VRG, University of Tennessee Medical Center, Knoxville, TN, USA.
  • Van Eygen V; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Luo D; Janssen Pharmaceuticals, LLC, Titusville, NJ, USA.
  • Vijgen L; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Gamil M; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Kakuda TN; Alios BioPharma, Inc. part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA.
  • Ouwerkerk-Mahadevan S; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Van Remoortere P; Janssen Pharmaceuticals, LLC, Titusville, NJ, USA.
  • Beumont M; Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.
J Viral Hepat ; 25(6): 631-639, 2018 06.
Article em En | MEDLINE | ID: mdl-29274193
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Hepatite C Crônica / Simeprevir / Sofosbuvir / Genótipo / Imidazóis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Viral Hepat Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepacivirus / Hepatite C Crônica / Simeprevir / Sofosbuvir / Genótipo / Imidazóis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Viral Hepat Ano de publicação: 2018 Tipo de documento: Article